i n addition to compromising patient safety, surgical site infections (ssis) represent a substantial burden on us healthcare costs. more than serving as a hospital quality measure-increasingly important for hospital reimbursements 1 -ssis are associated with an extended length of hospital stay by 10 days, representing an additional $1.6-billion annual burden on the healthcare system. [2] [3] [4] With the highest ssi rates, the more than 260,000 patients undergoing colorectal surgery each year appear at
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Jashvant Poeran, m.D., Ph.D. 1 • Isaac Wasserman, M.P.H. 2 nicole Zubizarreta, m.P.h. 1 • Madhu Mazumdar, Ph.D. 1 particular risk despite prophylactic antibiotics, the cornerstone of ssi prevention. 5 Current guidelines recommend the use of antibiotics covering both aerobic and anaerobic bacteria; however, the relative efficacy of different regimens has yet to be established. 6 moreover, despite numerous trials assessing optimal antibiotic prophylaxis strategies for colorectal surgery, few studies have assessed real-world antibiotic prophylaxis practice on a national scale with respect to ssi risk. 7, 8 notable exceptions are the Veterans affairs surgical Quality improvement Program 9 (n = 5750) and the michigan surgical Quality Collaborative 5 (n = 4331); instead of, studies that compared different antibiotic prophylaxis regimens in colorectal surgery. although these studies demonstrate that the type of antibiotic prophylaxis matters in mitigating ssi risk after colorectal surgery, they are burdened by small and localized samples while also lacking the most recent data. using a large, national, claims-based database we, therefore, sought to describe the real-world use of antibiotic prophylaxis (type and duration) in open colectomies and quantify the odds of developing an ssi for each prophylaxis regimen.
PATIENTS AND METHODS

Data Source and Study Design
in this retrospective cohort study we used data from the Premier Perspective database (Premier inc, Charlotte, nC). this database contains information on patient hospitalizations nationwide from January 2006 to December 2013 and includes International Classification of Diseases, Ninth Revision, Clinical Modification (iCD-9 Cm), codes; Current Procedural terminology codes; and billed items. these data meet the deidentification requirements as defined by the health insurance Portability and accountability act and was exempt from consent requirements of the mount sinai medical Center institutional Review Board (project hs .
Study Sample
the study sample contained patients who underwent an open colectomy 10 (right hemicolectomy, left hemicolectomy, resection of transverse colon, sigmoidectomy, or other; indicated by iCD-9 Cm procedure codes 45.7X, 45.82, and 45.83). exclusion criteria were based on previous studies. 11, 12 Patients were excluded (fig. 1) if they had an unknown sex or discharge type (n = 321), systemic antibiotic use before surgery (n = 77,043), no claims for antibiotic use on the day of surgery (n = 20,323), a switch in antibiotic class or gaps in antibiotic use of ≥1 day (as to distinguish between treatment and prophylaxis; n = 59,510), multiple procedures during the same hospitalization (n = 4085), were treated at a hospital performing less than 30 colectomies (to ensure sufficient sample size per cluster; n = 1274), 13 or died within 2 days of surgery (n = 861).
Study Variables
the main exposures of interest were the type of prophylactic antibiotic used and the duration of the use of prophylactic antibiotics. type of prophylactic antibiotic was categorized into cefotetan, cefoxitin, ampicillin with sulbactam, ertapenem, metronidazole with cefazolin, and "other" (for a full list of "other" medications, see appendix i; table 1); duration of prophylaxis was categorized into day of surgery only (day 0), day of surgery and the day after (day 0+1), and >1 day after surgery (day 1+ 15 ; 2) iCD-9 codes and billing for a wound culture; and 3) only billing for a wound culture. We believe that the use of varying definitions will demonstrate the robustness of our main effects of interest. unfortunately, the use of billing information does not allow us to reliably differentiate between superficial and deep wound infections; our ssi variables therefore represent a combination of both.
Statistical Analysis
first we assessed the univariable association between type of antibiotic use and study variables using χ 2 tests and t tests for categorical and continuous variables. We then performed multilevel, multivariable logistic regressions to measure the association between type and duration of antibiotic use and the 3 definitions of ssi. models included a random intercept term that varies at the level of each hospital, accounting for a correlation of patients within hospitals. the multivariable models were adjusted using all of the variables found significant at the p < 0.15 level from the univariable tests and deemed clinically important. adjusted oRs, 95% Cis, and p values are reported. model discrimination was evaluated using the c-statistic. all of the analyses were performed in sas version 9.4 statistical software (sas institute, Cary, nC).
RESULTS
the final study cohort consisted of 90,725 patients undergoing an open colectomy at 445 hospitals between January 2006 and December 2013. overall, 42% (n = 37,883) of patients received cefoxitin as prophylaxis; this was 18% (n = 16,531) for ertapenem, 10% (n = 9388) for cefotetan, 10% (n = 9006) for metronidazole with cefazolin, 8% (n = 6888) for ampicillin/sulbactam, and 12% (n = 11,029) for "other" antibiotics. furthermore, 52% (n = 46,788) received antibiotic prophylaxis only on the day of operation; 29% (n = 25,871) received prophylaxis on the day of the operation and the following day, and 20% (n = 18,066) received prophylaxis that lasted longer than the day after the operation. figure 2 shows the overall distribution of type of antibiotic, as well as subgrouped by day 0, day 0+1, and day 1+. appendix i contains a list of all of the antibiotics included under "other." the most commonly used "other" medication was metronidazole with quinolone (n = 8705; 79% of all "other" medications).
table 1 provides a breakdown of type of prophylactic antibiotic used by patient, including healthcarerelated, procedure-related, comorbidity, and outcome (ssi) variables. the majority of variables were univariably associated with the type of antibiotic used. interestingly, the use of ertapenem rapidly increased from 6% of all patients in 2006 to 29% in 2013 (row percentages, not shown in table 1 ). in addition, the mean length of hospitalization was highest among patients administered "other" antibiotics (8.8 days) and ampicillin with sulbactam (8.3 days), whereas the highest costs of hos- pitalization were seen for those administered "other" antibiotics ($19,916), and the highest Charlson Comorbidity index was seen for those on metronidazole with cefazolin (2.51; all p < 0.0001). the overall ssi prevalence, defined by only iCD-9 codes, was 5.2% (n = 4750), varying from 3.5% (metroni-dazole with cefazolin) to 5.9% (cefotetan). in general, estimated prevalences were lower for the other ssi definitions.
after adjustment for relevant covariates ( with sulbactam (oR = 0.71 (95% Ci, 0.63-0.82)), ertapenem (oR = 0.65 (95% Ci, 0.58-0.71)), and metronidazole with cefazolin (oR = 0.56 (95% Ci, 0.49-0.64); all p < 0.05). this pattern did not change when using the varying ssi definitions. the duration of prophylaxis was not significantly associated with ssi risk. the model c-statistics varied between 0.83 and 0.91, indicating good model discrimination.
DISCUSSION
although several others have assessed differences between antibiotic prophylaxis regimens in open colectomies, 7 to our knowledge this is the largest nationwide study representing real-world clinical practice among 90,725 patients from 445 us hospitals over 8 years. We demonstrated significant variations in antibiotic prophylaxis practices for open colectomies; whereas cefoxitin was most commonly used (42%), the role of ertapenem increased from 6% in 2006 to 29% in 2013 (of all prophylactics used). moreover, the type of antibiotic used appeared to be associated with ssi risk, with lower (vs cefoxitin) odds seen for ampicillin with sulbactam (29% decreased odds), ertapenem (35% decreased odds), and metronidazole with cefazolin (44% decreased odds). these effects remained with varying definitions of ssi. interestingly, the duration of prophylaxis was not significantly associated with ssi risk. Previous attempts to describe antibiotic prophylaxis choice and ssi rates suffer from small population size or diverse study design, and the optimal regimen of antibiotic prophylaxis for open colectomies has yet to be established. 8 the most commonly used prophylactic (cefoxitin) in our study differs from what was found in the only other similarly large description of clinical practice in colectomies using medicare data in 2005. using a random sample of 5279 medicare inpatients undergoing colon surgery, Brat-zler et al 16 found the most commonly used prophylactic to be cefotetan (52.8%), with only 30.7% receiving cefoxitin. similarly, using data from the michigan surgical Quality Collaborative (n = 3002), hendren et al 17 also found variations in antibiotic choice, with cefoxitin used in 20.0%, whereas metronidazole with cefazolin and ertapenem were used in 18.5% and 16.9%. in addition to this variation, we also demonstrated an increasing use of ertapenem. this may be because of an increasing number of studies in which ertapenem compares favorably with other antibiotics in ssi prevention. 5, 10, 18, 19 one of the main drivers in particular may have been the highly publicized 2006 trial by itani et al, 10 which showed ertapenem to be more effective than cefotetan in the prevention of ssis in patients undergoing elective open colorectal surgery. in addition, ertapenem covers both anaerobes and aerobes found in bowel lumen, has a relatively long half-life (preventing the need for a second administration), and has a similar safety profile compared with other prophylaxis choices. 10, 20, 21 examining real-world clinical practice, we also observed a deviation from recommended antibiotic prophylaxis guidelines. according to the 2013 surgical infection society Guidelines, antibiotic prophylaxis should be "continued for no more than 24 hours and can typically be stopped when the procedure is completed. 19 " We found that 48% of patients received prophylactics beyond the day of surgery, meaning in only 52% of cases prophylaxis lasted for just the day of surgery, as recommended by current guidelines. this is higher than the 41% of patients discontinuing prophylaxis within 24 hours of the end of surgery found in the 2005 medicare study. 16 the overall ssi rate was 5.2% in our study, lower than the rates found in other studies and most probably an underestimation, because rates have been shown to vary from 5% up to 30%. 8, 10, 22, 23 important factors affecting this variation are differences in clinical case definition, 24 in definition based on billing information (in our study we varied between iCD-9 codes and billing for wound cultures), and in followup time. 25, 26 indeed, 50% of ssi cases have been shown to occur after discharge 26 and thus were not captured in our data. importantly, however, this underestimation is likely to be distributed equally among all types of antibiotic prophylaxis. to our knowledge, there is no literature suggesting differing rates of postdischarge incidence of ssi by antibiotic choice. therefore, although absolute risk of ssi may be underestimated, we expect the comparison of relative odds of ssi to still be valid. interestingly, we found that antibiotic choice (after adjustment for relevant covariates) was significantly associated with ssi risk, with lower odds consistently seen for ampicillin with sulbactam, ertapenem, and metronidazole with cefazolin. this is comparable to results found in a study using data from the michigan surgical Quality Collaborative, including 4331 patients undergoing a colectomy in 24 different michigan hospitals between 2008 and 2010. here, the authors compared ssi rates between surgical Care improvement Project-recommended antibiotic prophylactic choices with those that were non-surgical Care improvement Project compliant. 5 the authors found that surgical Care improvement Project-compliant antibiotics (ciprofloxacin with metronidazole, metronidazole with cefazolin, and ertapenem) were associated with decreased odds of developing an ssi. the favorable comparison of metronidazole with cefazolin and ertapenem against cefotetan and cefoxitin is confirmed by the findings in the present study. moreover, among 5750 veterans undergoing a colectomy at 112 different Veterans affairs hospitals between 2005 and 2009, metronidazole with cefazolin again appeared to be associated with the lowest ssi rates, whereas second-generation cephalosporins accounted for the majority of antibiotic prophylaxis. 9 although we do not know the reasons for antibiotic choices in our study, 1 important factor contributing to differences in the effectiveness of antibiotic prophylaxis might be an emerging resistance of common antibiotics used in prophylaxis to Bacteroides fragilis, the most commonly isolated organism in these ssis. 27 in particular, the resistance of Bacteroides to clindamycin has been found to range from 20% to 60%, whereas increased resistance has also been found in cefoxitin, cefotetan, and ampicillin with sulbactam. 9, 28 although a significant proportion of patients in our study received antibiotic prophylaxis beyond the day of surgery (48%), the duration of prophylaxis was not associated with ssi risk, thus supporting the rationale behind current guidelines. 7, 19 Between 1978 and 2011, 33 studies examined the association between duration of prophylaxis and ssi; combined, their data showed no association between duration of antibiotic prophylaxis and ssi risks. 7 it is unclear what is behind the observed extended use of prophylactic antibiotics; qualitative studies geared toward this question will shed some light on this intriguing issue and thus provide targets for intervention.
next to replication and validation of our study results using other data sources, we believe that the current study hints toward potentials for improvement in the perioperative care for these patients. this opportunity pertains particularly to the most commonly used prophylactic (cefotetan) being associated with the highest odds for ssis and 48% of patients receiving antibiotic prophylaxis beyond the day of surgery, despite this practice not showing altered odds for ssi risk. Despite general consensus on the importance of ssi prevention in hospital policies, there is a lack of studies looking into so-called return-on-investment calculations from the hospital perspective. using data from the Johns hopkins health system for a variety of surgeries, shepard et al 29 found the change in annual profit attributed to ssis was approximately $650,000-a conservative measure given their methodology-thus illustrating the financial incentive for hospitals to reduce ssis. the results from our study suggest that even relatively straightforward alterations in antibiotic prophylaxis strategies may yield substantial patient safety and economic benefits. future studies should explore the full scope of benefits and harms while also evaluating implementation strategies and their costs.
the main limitation of our study is the lack of detailed clinical information in the billing dataset used; data are collected for the purpose of billing, not specific research questions. therefore, important information such as reasons behind antibiotic choice and duration of prophylaxis, ssi pathogens, type of ssi (deep or superficial), or other interventions that might influence ssi risk (eg, mechanical bowel preparation with or without oral antibiotics) cannot be taken into account, and thus residual confounding cannot be ruled out. however, although there is evidence on specifically the benefits of the latter on ssi risk, some reports suggest a decrease in the use of oral antibiotics 30 ; 92% of surgeons reported using oral antibiotics in 1992, 31 whereas this was only 36% in 2010. 32 in addition, information from billing databases does not necessary reflect what is actually administered to the patient, because there might be a mismatch between the two. Given the deidentified nature of the dataset, auditing was not possible. however, we expect the effect of the mismatch to be minimal, because this should be unrelated to ssi risk and type/duration antibiotics. another limitation, partly because of the lack of clinical information, pertains to the definition of ssi from billing data for the inpatient period only. this appears particularly important because a substantial proportion (≈50%) of infections after colorectal surgery occur after hospital discharge. 26 this limitation would theoretically only affect our results when the occurrence of ssi postdischarge is dependent on choice and duration of antibiotic prophylaxis. although this assumption might be debatable, we feel confident in our findings because they confirm those found in previous studies. our study might also have been burdened by differential definitions of ssi. although we have tried to account for this by assessing the effects of antibiotic choice and duration on 3 different ssi definitions, the issue of differences in clinical interpretation persists. hedrick et al 24 showed recently that there is a poor agreement between the ssi definition put forward by the Centers for Disease Control and Prevention and a more objective ssi scoring system. although this is an important issue for particularly the validity of ssi reporting, we believe that, for the current study, the comparison between differences in clinical interpretation and differential (billing) definitions is independent of antibiotic choice and therefore reducing its effect on the current findings. also, although the rate of laparoscopic colectomy is increasing, our results only apply to those undergoing open colectomies. 33 We specifically only studied patients undergoing open colectomies, because their ssi risk is higher and therefore the effect of antibiotic practices is expected to be more profound. 34 Because an increasing number of patients are undergoing laparoscopic surgery, it would indeed be of interest to assess antibiotic practices in this group in future studies. adding to the issue of generalizability is the use of multiple exclusion criteria. these were used to minimize confounding (next to covariate adjustment), however, with the risk of compromising generalizability. this indeed is an inevitable limitation of retrospective studies. the explicit statement of our exclusion criteria should ensure the correct interpretation of our results.
CONCLUSION
in this large, nationwide study, we found significant variations in antibiotic prophylaxis practices for open colectomies, with cefoxitin the most commonly used, and a rapid increase of ertapenem usage. the type of prophylactic antibiotic used appeared to be associated with ssi risk, with 29% to 44% lower odds seen for ampicillin with sulbactam, ertapenem, and metronidazole with cefazolin as compared with the most commonly administered antibiotic, cefoxitin. these effects persisted with varying definitions of ssi. lending support to current guidelines, the duration of prophylaxis was not significantly associated with ssi risk. 
